Cervical cancer kills more than 310,000 women every year globally - more deaths than during childbirth. 90% of deaths are in lower and middle-income countries. HPV infection is the main cause of cervical cancer globally, and without large-scale interventions in both prevention and control, the number of deaths is forecast to rise a further 50% by 2030.
Gavi, the Vaccine Alliance supports the poorest countries of the world to get access to affordable HPV vaccines. Since 2016, Girl Effect and Gavi have worked together on a game-changing $10 million collaboration to leverage the power of brands to build girls’ demand for the HPV vaccine and encourage girls to use health services at critical times in their lives. The four-year partnership, focusing on Rwanda, Ethiopia, Malawi, and Tanzania, works to understand what girls already know about the HPV vaccine, then activates Girl Effect’s youth brands to increase girls’ knowledge and shift their attitudes towards the vaccine and other health services - engaging girls through our digital platforms, magazines, radio shows, music and more.
The partnership integrates robust monitoring and evaluation processes to not only measure the impact of our youth brands on supply-side uptake in Rwanda (Ni Nyampinga), Ethiopia (Yegna), Malawi (Zathu), and Tanzania (Tujibebe), but also how the power of a brand can drive positive health outcomes more broadly. The research will make the case for more holistic, girl-centred strategies to drive behaviour change and create new opportunities in delivering integrated adolescent health models.
Want to know more about our impact?
As we now have evidence of what works and how it can be used effectively by others, Girl Effect has launched a Girl Focus Toolkit to support ministries of health in countries where we do not operate to develop effective ‘girl-focused’ HPV vaccine communications.